This article is more than 5 years old. Information may no longer be current.

FDA approves Tecnis toric one-piece IOL

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Tecnis toric one-piece IOL has been approved by the U.S. Food and Drug Administration for cataract patients with pre-existing corneal astigmatism and is being launched in the United States, according to a news release from Abbott.

The IOL meets the American National Standards Institute’s benchmark for rotational stability and is capable of correcting loss of focus from pre-existing astigmatism of 1 D or greater, the release said. It also can minimize spherical aberrations.

The Tecnis toric IOL is meant for patients who seek improved uncorrected distance vision, reduced residual refractive cylinder and greater spectacle independence, according to the Tecnis toric website.